* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
GlaxoSmithKline Pharmaceuticals Days Payable Chart
NSE:GLAXO vs LLY, JNJ, ABBV: Days Payable Comparison
For the Drug Manufacturers - General subindustry, GlaxoSmithKline Pharmaceuticals's Days Payable, along with its competitors' market caps and Days Payable data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
GlaxoSmithKline Pharmaceuticals Days Payable vs Drug Manufacturers Industry
For the Drug Manufacturers industry and Healthcare sector, GlaxoSmithKline Pharmaceuticals's Days Payable distribution charts can be found below:
* The bar in red indicates where GlaxoSmithKline Pharmaceuticals's Days Payable falls into.
GlaxoSmithKline Pharmaceuticals Days Payable Calculation
Days Payable indicates the number of days that the account payable relative to cost of goods sold the company has. An increase of Days Payable may suggest that the company delays paying its suppliers.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
GlaxoSmithKline Pharmaceuticals (NSE:GLAXO) has a Days Payable of 151.26 as of Mar. 2026. Days payable represents the average amount of days a company waits to pay its invoices from suppliers. View historical data on GlaxoSmithKline Pharmaceuticals and its competitors. This is 23% above median its historical median of 123.40. Over the past decade, GlaxoSmithKline Pharmaceuticals' Days Payable has ranged from 74.72 to 165.23. According to the industry distribution chart, GlaxoSmithKline Pharmaceuticals ranks #212 out of 920 companies in the Drug Manufacturers industry, placing it in the top 23%.
Is GlaxoSmithKline Pharmaceuticals' Days Payable too high?
GlaxoSmithKline Pharmaceuticals' current Days Payable of 151.26 is 23% above median its 10-year median of 123.40. Over the past 10 years, this metric has ranged from a low of 74.72 to a high of 165.23. The Drug Manufacturers industry median Days Payable is 90.84. GlaxoSmithKline Pharmaceuticals' value of 151.26 is 66.5% above this industry median. Based on the distribution chart, GlaxoSmithKline Pharmaceuticals ranks #212 out of 920 companies in the Drug Manufacturers industry, which is in the top quartile — a strong position relative to peers. Overall, GlaxoSmithKline Pharmaceuticals has a GF Score™ of 74/100 and is considered Fairly Valued, reflecting its overall financial health beyond just this single metric.
How does GlaxoSmithKline Pharmaceuticals' Days Payable compare to LLY and JNJ?
According to the Drug Manufacturers industry distribution chart, GlaxoSmithKline Pharmaceuticals ranks #212 out of 920 companies for Days Payable. This places GlaxoSmithKline Pharmaceuticals in the top 23% of its industry — outperforming the majority of peers. The industry median Days Payable is 90.84. GlaxoSmithKline Pharmaceuticals' value of 151.26 is 66.5% above this benchmark. Historically, GlaxoSmithKline Pharmaceuticals' own Days Payable has ranged from 74.72 to 165.23 over the past decade. While the company's 10-year median is 123.40 vs. the industry median of 90.84, GlaxoSmithKline Pharmaceuticals has consistently been above the industry average. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Days Payable for a Drug Manufacturers company?
The median Days Payable among Drug Manufacturers companies is 90.84, based on 920 companies in the industry. Companies in the top quartile (top 25%) have a Days Payable significantly above this median, while those in the bottom quartile fall well below. However, Days Payable should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. GlaxoSmithKline Pharmaceuticals's current Days Payable of 151.26 is 66.5% above the industry median. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Days Payable mean?
A high Days Payable can signal that a stock is expensive relative to its fundamentals. Days payable represents the average amount of days a company waits to pay its invoices from suppliers. View historical data on GlaxoSmithKline Pharmaceuticals and its competitors. For the Drug Manufacturers industry, the median Days Payable is 90.84 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. GlaxoSmithKline Pharmaceuticals's current Days Payable is 151.26, which is 23% above median its own 10-year median of 123.40. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is GlaxoSmithKline Pharmaceuticals stock overvalued right now?
Based on GuruFocus' analysis, GlaxoSmithKline Pharmaceuticals (NSE:GLAXO) is currently considered Fairly Valued. The stock's GF Value™ is ₹2,610.20, compared to a current price of ₹2,450.30 — trading 6.1% below its estimated fair value. The current Days Payable is 151.26, which is 23% above median its 10-year median of 123.40 and 66.5% above the Drug Manufacturers industry median of 90.84. GlaxoSmithKline Pharmaceuticals' overall GF Score™ is 74/100 with 1 warning sign to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Days Payable calculated?
Days Payable is calculated from a company's financial statements. For GlaxoSmithKline Pharmaceuticals (NSE:GLAXO), the current Days Payable is 151.26 as of Mar. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Is GlaxoSmithKline Pharmaceuticals (NSE:GLAXO) Overvalued in 2026?
Based on GuruFocus' analysis, GlaxoSmithKline Pharmaceuticals stock appears to be undervalued.
The current stock price of ₹2,450.30 is trading 6.1% below its estimated GF Value™ of ₹2,610.20.
GuruFocus considers GlaxoSmithKline Pharmaceuticals to be Fairly Valued.
Key valuation signals for NSE:GLAXO:
Days Payable: 151.26 (23% above median its 10-year median of 123.40)
GF Value™: ₹2,610.20 vs. price of ₹2,450.30 (6.1% below fair value)
Industry Position: 66.5% above the Drug Manufacturers median (#212 of 920)
No single metric tells the full story. See the NSE:GLAXO stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.
GlaxoSmithKline Pharmaceuticals Business Description
GlaxoSmithKline Pharmaceuticals Ltd is engaged interalia, in the business of manufacturing, distributing and trading in pharmaceuticals. It is healthcare organisation focused on uniting science, technology and talent to get ahead of disease. The company's product portfolio comprises a broad range of General Medicines which includes anti-infectives, pain management, vitamins, minerals, nutritionals, hormones, dermatologicals, vaccines for both children and adults, and specialty medicines for respiratory and oncology. Its focused brands are Augmentin, Ceftum, Flutivate, T-bat, Betnovate, Neosporin, Tenovate, Physiogel, Calpol and Calpol T. The company has single reportable segment. The company has presence in India, and also Outside India. It generates majority of revenue from India.
74GF Score
Get the complete analysis for NSE:GLAXO
Days Payable is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
NSE:GLAXO has been successfully added to your 
